| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2019 - 2023 |
| Market Size (2025) | USD 148.06 Million |
| Market Size (2030) | USD 195.63 Million |
| CAGR (2025 - 2030) | 5.73 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Indonesia Diabetes Care Devices Market Analysis
The Indonesia Diabetes Care Devices Market size is estimated at USD 148.06 million in 2025, and is expected to reach USD 195.63 million by 2030, at a CAGR of 5.73% during the forecast period (2025-2030).
Diabetes in Indonesia is considered a major health problem and has been a concern. Diabetes specialists have created recommendations for preventing and controlling diabetes to address the growing number of diabetics in Indonesia. Diabetes management is critical to preventing serious consequences such as neuropathy, nephropathy, retinopathy, microvascular disease, and cardiovascular disease.
Pharmacologic therapy such as oral medicines and insulin, as well as non-pharmacologic therapies such as lifestyle changes, are still considered modern approaches for diabetes management. These therapies are only possible through diabetes teaching programs that promote self-care management. Diabetes education programs are provided by healthcare providers in Indonesia. In Indonesia, the availability of certified diabetic educators is restricted, resulting in a scarcity of qualified health care professionals (HCPs) to educate persons with diabetes.
Furthermore, the increasing focus on self-care and self-monitoring among individuals with diabetes has also played a role in driving the market growth. Many individuals now prefer to monitor their blood glucose levels at home, rather than visiting healthcare facilities. This has led to a higher demand for blood glucose devices that can be used easily and effectively at home.
Overall, the rising number of diabetes cases in Indonesia has created a significant market opportunity for blood glucose devices. The combination of increased awareness, government initiatives, technological advancements, and changing patient preferences has fueled the growth of this market. As the diabetes epidemic continues to grow, the demand for blood glucose devices is expected to further increase, driving the market growth even further.
Indonesia Diabetes Care Devices Market Trends
Management Devices Hold Highest Market Share in Indonesia Diabetes Care Devices Market
Patients with Type 1 diabetes (T1D) must maintain healthy lifestyle conditions, which are impacted by t person's personality traits, social interactions, socioeconomic circumstances, and environmental living factors. TContinuousglucose monitoring (CGM) with multiple daily injections (MDI) has shown a reduction in nonsevere and severe hypoglycemia in people with T1D prone to this adverse event.
Insulin pump therapy has long been established as a reliable method for administering insulin to individuals with type 1 diabetes (T1DM). These pumps have been proven to be an effective treatment option for T1DM patients of all ages, allowing for insulin delivery that closely mimics the body's natural production in cases where the pancreas is unable to produce insulin. Some pump models even come equipped with remote controls, giving parents of young children the ability to remotely suspend or administer insulin while their child is playing or eating.
Insulin infusion pumps have been shown to minimize drastic fluctuations in blood glucose levels, cause less discomfort, and provide more precise insulin delivery compared to traditional injections. These advantages are expected to drive growth in the market for insulin pumps.
The market is further bolstered by the increasing number of vendors, ongoing research and development efforts, advancements in technology, and the widespread availability of advanced products worldwide. Additionally, favorable reimbursement policies in developed countries and growing awareness programs in developing nations are contributing to the market's expansion.
Understand The Key Trends Shaping This Market
Download PDF
Increasing Type -1 Diabetes Population in Indonesia
In terms of the number of people with diabetes, Indonesia ranks seventh in the world. In Indonesia, people's health is primarily covered by national government insurance. Government insurance covers medical requirements such as consultation, hospitalization, insulin, and needles through designated clinics, hospitals, and licensed pharmacies. However, due to a lack of knowledge and information on Type 1 diabetes, a misunderstanding occurred, resulting in insulin access limits.
The amount of insulin made available through government insurance was limited. For example, a child with Type 1 diabetes who is supposed to receive eight insulin pens per month was only given five insulin pens per month, requiring the parents to purchase the remaining three pens at their own expense. They could not meet their child's insulin needs if they did not have the money. One of the world's most populous nations,
Indonesia has about 11 million diabetics, or 6.3% of the population. As a result, Indonesia ranks among the nations with the highest proportion of people with diabetes. Diabetes is one of Indonesia's leading causes of death, according to WHO data from 2016. Diabetes management strategies in Indonesia include pharmacological treatment, education, physical activity, and dietary management.
The COVID-19 pandemic and the related social restriction policy implemented by the Indonesian government to reduce transmissions have affected diabetes management and increased diabetes-related complications in a nation with a large diabetes population.
As a result, the diabetes care devices market in Indonesia is predicted to expand gradually in the coming years.
Get Analysis on Important Geographic Markets
Download PDF
Indonesia Diabetes Care Devices Industry Overview
The new technologies in diabetes devices, like continuous glucose monitoring, increased the market for monitoring devices. The mergers and acquisitions between the players, like the acquisition of TypeZero Technologies by Dexcom, are paving the way for automated insulin delivery. The acquisition has sent Dexcom ahead on its way in the race to create an artificial pancreas system rather than merely offering a boost to the continuous glucose monitoring devices market.
Indonesia Diabetes Care Devices Market Leaders
-
Medtronic
-
Roche
-
Novo Nordisk
-
Abbott
-
Dexcom
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Indonesia Diabetes Care Devices Market News
- October 2023: Phillips-Medisize and GlucoModicum will collaborate on the creation of a novel CGM device known as the Talisman. This innovative device integrates magnetohydrodynamic technology, advanced algorithms, and biosensors. Additionally, it is designed to connect to a smartphone application for efficient data collection.
- February 2022: Indonesia's Ministry of Health launched a sectoral e-Katalog for medical devices. Previously, e-Katalog was managed by LKPP, referred to as the national e-Katalog, for all products procured by government institutions street lighting to pacemakers. LKPP e-Katalog is now split into a national e-Katalog for items required nationally and sectoral e-Katalogs, specific to ministries such as the Ministry of Health.
Indonesia Diabetes Care Devices Industry Segmentation
A glucose meter, commonly known as a "glucometer", is a device used in the medical field to estimate the concentration of glucose in the bloodstream. It can also involve a glucose paper strip that is immersed in a sample and then compared to a glucose chart. Thailand Diabetes Care Devices Market is segmented into devices. The report offers the value (in USD) and volume (in Units) for the above segments.
| Monitoring Devices | Self-monitoring Blood Glucose Devices | Glucometer Devices | |
| Test Strips | |||
| Lancets | |||
| Continuous Blood Glucose Monitoring | Sensors | ||
| Durables | |||
| Management Devices | Insulin Pump | Insulin Pump Device | |
| Insulin Pump Reservoir | |||
| Infusion Set | |||
| Insulin Syringes | |||
| Insulin Cartridges | |||
| Disposable Pens | |||
Need A Different Region or Segment?
Customize Now
Indonesia Diabetes Care Devices Market Research FAQs
How big is the Indonesia Diabetes Care Devices Market?
The Indonesia Diabetes Care Devices Market size is expected to reach USD 148.06 million in 2025 and grow at a CAGR of 5.73% to reach USD 195.63 million by 2030.
What is the current Indonesia Diabetes Care Devices Market size?
In 2025, the Indonesia Diabetes Care Devices Market size is expected to reach USD 148.06 million.
Who are the key players in Indonesia Diabetes Care Devices Market?
Medtronic, Roche, Novo Nordisk, Abbott and Dexcom are the major companies operating in the Indonesia Diabetes Care Devices Market.
What years does this Indonesia Diabetes Care Devices Market cover, and what was the market size in 2024?
In 2024, the Indonesia Diabetes Care Devices Market size was estimated at USD 139.58 million. The report covers the Indonesia Diabetes Care Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Indonesia Diabetes Care Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Indonesia Diabetes Care Devices Industry Report
Statistics for the 2025 Indonesia Diabetes Care Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Indonesia Diabetes Care Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
